Zacks.com on MSN2d
Nevro (NVRO) Soars 13.9%: Is Further Upside Left in the Stock?
Nevro (NVRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Hosted on MSN1d
Piper Sandler Upgrades Nevro (NVRO)
Fintel reports that on February 7, 2025, Piper Sandler upgraded their outlook for Nevro (NYSE:NVRO) from Underweight to ...
Nevro price target raised to $5.85 from $5 at Baird
Baird raised the firm’s price target on Nevro (NVRO) to $5.85 from $5 and keeps a Neutral rating on the shares. The firm noted its acquisition ...
Globus acquisition of Nevro ‘fairly low-risk bet,’ says BTIG
BTIG says Globus Medical’s (GMED) announced acquisition of Nevro (NVRO) “is surprising on the surface.” Investors did not expect Globus would ...
MassDevice2d
Globus Medical to acquire Nevro for $250M
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
Stifel维持Globus Medical买入评级，目标价92美元，NVRO收购在即
周四，在Globus Medical (NYSE: GMED )宣布以约2.5亿美元股权价值收购Nevro Corp. (NVRO)后，Stifel分析师维持该公司股票的买入评级和92.00美元的目标价。根据InvestingPro数据，Globus Medical保持着优秀的财务状况，整体评分为"优秀"，流动性指标强劲。此次交易导致Globus Medical修改了2025年每股收益 ...
Zacks.com on MSN2d
Nevro (NVRO) Upgraded to Buy: What Does It Mean for the Stock?
Nevro (NVRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).